CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...
On Friday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Moderna vaccine should now seek out a booster five months after ...
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...
Moderna seeks emergency use authorization for Covid-19 vaccine for children ages 6 months to 5 years
NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback